A global research study conducted during the COVID-19 pandemic revealed a negative impact on diabetes patients. Sight loss and non-COVID-related deaths among those with diabetes increased, particularly among children and adolescents. Direct impacts of the pandemic on diabetes management included significantly more severe new cases of Type 1 diabetes. Additionally, diabetes-related mortality rose during the first wave of the pandemic, likely due to reduced healthcare access. Younger people and minority groups were most affected. The authors stress the need for pandemic planners to consider this data and ensure consistent, equitable access to diabetes medication and care. Future implications of these findings will be examined in the next decade.
Source link
Non-COVID-19 mortality among people with diabetes increased during the pandemic
